Stoke Therapeutics Inc buy Guggenheim
Start price
07.02.26
/
50%
€26.60
Target price
07.02.27
€50.81
Performance (%)
11.28%
Price
04.03.26
€29.60
Summary
This prediction is currently active. The prediction currently has a performance of 11.28%. This prediction currently runs until 07.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -3.896% | -3.896% |
| iShares Core DAX® | -6.016% | -4.595% |
| iShares Nasdaq 100 | 0.511% | 0.164% |
| iShares Nikkei 225® | -7.156% | -2.215% |
| iShares S&P 500 | -0.257% | -0.841% |
Comments by Guggenheim for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (NASDAQ:STOK) is now covered by analysts at Guggenheim. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for STOK provided by MarketBeat